Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine vs Dorzolamide vs Brinzolamide Adjunctive to PGAs
NCT00675207Phase 4Completed
- Sponsor
- Northwestern Ophthalmic Institute
- Start
- Jan 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine transdermal lotion, dorzolamide, brinzolamide in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Northwestern Ophthalmic Institute. Started Jan 2006; status: completed.
02
Drugs
brimonidine transdermal lotiondorzolamidebrinzolamide
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT00675207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675207.